Correlation Between CVS Health and Neurocrine Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CVS Health and Neurocrine Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CVS Health and Neurocrine Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CVS Health and Neurocrine Biosciences, you can compare the effects of market volatilities on CVS Health and Neurocrine Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CVS Health with a short position of Neurocrine Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of CVS Health and Neurocrine Biosciences.

Diversification Opportunities for CVS Health and Neurocrine Biosciences

-0.46
  Correlation Coefficient

Very good diversification

The 3 months correlation between CVS and Neurocrine is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding CVS Health and Neurocrine Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurocrine Biosciences and CVS Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CVS Health are associated (or correlated) with Neurocrine Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurocrine Biosciences has no effect on the direction of CVS Health i.e., CVS Health and Neurocrine Biosciences go up and down completely randomly.

Pair Corralation between CVS Health and Neurocrine Biosciences

Assuming the 90 days trading horizon CVS Health is expected to generate 2.74 times less return on investment than Neurocrine Biosciences. In addition to that, CVS Health is 1.2 times more volatile than Neurocrine Biosciences. It trades about 0.02 of its total potential returns per unit of risk. Neurocrine Biosciences is currently generating about 0.05 per unit of volatility. If you would invest  2,877  in Neurocrine Biosciences on August 27, 2024 and sell it today you would earn a total of  739.00  from holding Neurocrine Biosciences or generate 25.69% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy94.78%
ValuesDaily Returns

CVS Health  vs.  Neurocrine Biosciences

 Performance 
       Timeline  
CVS Health 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in CVS Health are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, CVS Health may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Neurocrine Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Neurocrine Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's fundamental drivers remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

CVS Health and Neurocrine Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CVS Health and Neurocrine Biosciences

The main advantage of trading using opposite CVS Health and Neurocrine Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CVS Health position performs unexpectedly, Neurocrine Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurocrine Biosciences will offset losses from the drop in Neurocrine Biosciences' long position.
The idea behind CVS Health and Neurocrine Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Equity Valuation
Check real value of public entities based on technical and fundamental data